At the ECCO 2025 Congress, researchers presented a study showing that machine learning can identify gut microbial biomarkers that differentiate IBD patients—particularly those with Crohn’s disease—from healthy individuals. The study analyzed stool samples from over 3,700 participants, finding that supervised machine learning had the highest diagnostic accuracy (AUC 0.971).
Trending
- Exploring Exhaled Breath as a New Platform for Gut Microbiome-Based Diagnostics (HCP Live)
- The Medical Futurist’s 100 Digital Health And AI Companies Of 2026 (The Medical Futurist)
- MedPAC signals need to bolster Medicare physician payments (American Medical Association)
- Want to Reach Nirvana? Try a Colonoscopy. (The New York Times)
- Aidoc Secures FDA Clearance for Healthcare’s First Comprehensive Foundation Model AI (AIdoc)
- NYU Langone Health Announces Gastrointestinal Cancer & Translational Research Leader Dr. Anirban Maitra as New Director of Perlmutter Cancer Center (NYU Langone Health)
- Bringing biomarker testing within reach: CLEAR for CRC to empower patients from day one (Colorectal Cancer Alliance)
- GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test (GRAIL)
